-- 周二收盘前，美国股指走低，半导体股下跌拖累科技股，而中东地缘政治局势恶化则推高原油期货价格。 纳斯达克综合指数下跌0.9%，收于24,675.1点；标普500指数下跌0.5%，收于7,138.2点；道琼斯工业平均指数下跌0.1%，收于49,124.9点。 据《华尔街日报》周一晚间援引知情人士报道，微软(MSFT)支持的OpenAI近期未能实现其新增用户和营收目标。报道援引知情人士的话称，首席财务官莎拉·弗莱尔(Sarah Friar)表示担忧，如果销售额增长速度不够快，OpenAI可能无力支付未来的计算合同费用。 据Finviz汇编的数据显示，市值超过2000亿美元的公司中，表现最差的主要是半导体公司，包括Arm Holdings (ARM)、Applied Materials (AMAT)、Arista Networks (ANET)、Broadcom (AVGO)和Oracle (ORCL)。 与此同时，据阿联酋通讯社报道，阿联酋将于5月1日起退出石油输出国组织（欧佩克）及其扩大版欧佩克+。 路透社周二援引一位不愿透露姓名的美国官员的话报道称，伊朗提出的结束中东战争的最新方案令美国总统特朗普不满，导致这场致命冲突持续陷入僵局。 西德克萨斯中质原油期货价格上涨3.7%，至每桶99.96美元；布伦特原油期货价格上涨2.7%，至每桶111.16美元。
Related Articles
Research
Research Alert: Equity Residential Delivers Slight Ffo Beat And Revenue Miss In Q1 2026
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:EQR delivered Q1 2026 FFO of $0.99, beating consensus by $0.02, though rental revenue of $780M slightly missed expectations. The company's blended lease rate of 1.5% remained flat Y/Y, with new lease rates declining 2.8% due to incentives offset by strong renewal rates of 4.7%. We maintain our Hold rating based on operating expense pressure suppressing cash NOI growth in 2026. Management guides for 2026 same-store revenue growth of 1.2%-3.2%, expense growth of 3.0%-4.0%, and cash NOI growth of 0.5%-2.5%, with strength expected in 2H 2026. EQR's coastal market strategy continues demonstrating value, with San Francisco leading at 6.5% revenue growth and New York at 4.6%, while expansion markets like Denver (-5.9%) and Atlanta (-2.0%) face new supply pressure. EQR has premium coastal markets where limited new supply enables pricing power, though higher operating costs remain a risk. The development pipeline totals $863M for 1,824 units when complete. Planned property acquisitions are $165M in 2026.
$EQR
Asia
Rua Bioscience Notes 'Significant Contraction' in Australian Medical Cannabis Prescribing Volumes Amid Regulatory Review
Rua Bioscience (NZE:RUA) said the Australian market has experienced "significant contraction" in medical cannabis prescribing volumes amid a Therapeutic Goods Administration review of the safety of unapproved products, according to a Wednesday filing with the New Zealand bourse.However, medicinal cannabis is showing "strong signs of maturity and growth" in international markets, especially in Europe, in the face of recent international developments and discourse of a global economic slowdown, Rua added.The company recently established RUA genetics in Canada, the second-largest cannabis market in the world after the US, adding to its presence in Germany, Australia, New Zealand, Czechia, and the UK, per the filing.In Australia, the company expects a market reset after the regulatory review is complete, and is working to establish its products in new clinic chains.Elsewhere, Rua plans to bring several products to the New Zealand market in the coming months, and is also working on product launches in Czechia scheduled for May. Additionally, the company is looking to expand in the UK with plans to incorporate its genetics through new channels and clinic chains.In Germany, the company believes there is strong demand for consistent and reliable suppliers as significant regulatory changes seem unlikely following a review during which distributors reduced stock and scaled back imports. The German market remains competitive and continues to show strong signs of growth, Rua said.
$NZE:RUA
Treasury
Market Chatter: Nvidia-Linked Data Center Raises $4.6 Billion From Junk Bond Sale
A Nevada data center project tied to Nvidia (NVDA) has raised $4.59 billion through a junk-bond sale, underscoring a rise in deals for AI infrastructure funding, Bloomberg reported on Tuesday, citing a person familiar with the matter.The deal, backed by Tract Capital Management and Fleet Data Centers, priced five-year notes at a 6.74% yield, the report said.The project, a 200-megawatt facility in Nevada, is expected to be leased to Nvidia.The deal was priced during broader volatility in data center-linked stocks and bonds, as concerns grow over whether the rapid expansion in AI-related spending will deliver expected returns, Bloomberg said.Nvidia did not immediately respond to' request for comment.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
$NVDA